Xconomy National

Archives

by in

Entry	Author	Date	Location
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy	Bruce V. Bigelow	02/03/12	San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News	Erin Kutz	02/03/12	Boston
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says	Luke Timmerman	02/01/12	Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug	Luke Timmerman	01/31/12	Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers	Erin Kutz	01/27/12	Boston
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More	Bruce V. Bigelow	01/26/12	San Diego
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race	Luke Timmerman	01/24/12	Boston
The Top 10 Traffic-Getting Stories at Xconomy San Diego	Bruce V. Bigelow	12/28/11	San Diego
San Diego Life Sciences Roundup: BeneChill, Sotera, Imthera, & More	Bruce V. Bigelow	12/16/11	San Diego
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers	Erin Kutz	12/16/11	Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition	Luke Timmerman	12/15/11	Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500	Luke Timmerman	12/12/11	National
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News	Erin Kutz	11/11/11	Boston
Vertex Stock Drops 17% Over Two Days, As Potent Hep C Rivals Emerge	Luke Timmerman	11/08/11	Boston
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011	Luke Timmerman	11/07/11	National
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News	Erin Kutz	10/28/11	Boston
Vertex Flips Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again	Luke Timmerman	10/27/11	Boston
This Week’s Xconomy Report on WGBH: Security Innovation, Vertex, West Coast Acquisitions, & More	Lilly O'Flaherty	10/21/11	Boston
Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News	Rebecca Zacks	10/21/11	Boston
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year	Luke Timmerman	10/19/11	Boston
Anadys Pharmaceuticals Surprises the Street, Gets Acquired by Roche for $230M	Luke Timmerman	10/17/11	San Diego
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos	Erin Kutz	10/13/11	Boston
Cocrystal, Led by Icos Vets and Stanford Nobelist, Hunts for Next Big Thing for Hepatitis C	Luke Timmerman	09/22/11	Seattle
Stirring the Pot Once in a While Doesn’t Hurt, and It Could Help Biotech Break its Malaise	Luke Timmerman	09/19/11	National
Cocrystal Discovery Snags $7.5M in Hepatitis C Collaboration With Teva	Luke Timmerman	09/15/11	Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue	Steve Worland	09/06/11	San Diego
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead	Luke Timmerman	09/06/11	National
The Fall of Pfizer: How Big is Too Big for Pharma Innovation?	Luke Timmerman	08/29/11	National
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO	Luke Timmerman	08/18/11	National
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus	Luke Timmerman	08/08/11	National
Page 1 of 8	next page »